Emma A. Harden

1.4k total citations
30 papers, 1.1k citations indexed

About

Emma A. Harden is a scholar working on Epidemiology, Virology and Oncology. According to data from OpenAlex, Emma A. Harden has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 9 papers in Virology and 6 papers in Oncology. Recurrent topics in Emma A. Harden's work include Herpesvirus Infections and Treatments (21 papers), Cytomegalovirus and herpesvirus research (18 papers) and Poxvirus research and outbreaks (8 papers). Emma A. Harden is often cited by papers focused on Herpesvirus Infections and Treatments (21 papers), Cytomegalovirus and herpesvirus research (18 papers) and Poxvirus research and outbreaks (8 papers). Emma A. Harden collaborates with scholars based in United States, Ukraine and New Zealand. Emma A. Harden's co-authors include Earl R. Kern, Caroll B. Hartline, Mark N. Prichard, Karl Y. Hostetler, James R. Beadle, Natalie Rodríguez, Nicole L. Kushner, Kathy A. Keith, Susan Carnachan and Ruth Falshaw and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry.

In The Last Decade

Emma A. Harden

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma A. Harden United States 16 738 239 236 231 184 30 1.1k
Sabrina Auerochs Germany 19 796 1.1× 136 0.6× 150 0.6× 130 0.6× 450 2.4× 21 1.2k
D. Reymen Belgium 13 265 0.4× 260 1.1× 83 0.4× 255 1.1× 182 1.0× 18 709
Teresa H. Bacon United Kingdom 12 597 0.8× 123 0.5× 99 0.4× 97 0.4× 142 0.8× 17 825
Matloob Husain New Zealand 20 634 0.9× 144 0.6× 102 0.4× 239 1.0× 496 2.7× 43 1.2k
L. J. N. Ross United States 22 890 1.2× 182 0.8× 125 0.5× 221 1.0× 236 1.3× 43 1.3k
Annalisa Macagno Italy 14 380 0.5× 447 1.9× 111 0.5× 73 0.3× 319 1.7× 16 1.4k
C G Bridges United Kingdom 14 514 0.7× 128 0.5× 77 0.3× 76 0.3× 108 0.6× 25 815
Chen‐Wen Yao Taiwan 17 99 0.1× 336 1.4× 66 0.3× 70 0.3× 268 1.5× 23 870
Olga Hrušková‐Heidingsfeldová Czechia 15 238 0.3× 336 1.4× 114 0.5× 87 0.4× 276 1.5× 39 672
Elcira C. Villarreal United States 15 320 0.4× 73 0.3× 41 0.2× 111 0.5× 168 0.9× 21 536

Countries citing papers authored by Emma A. Harden

Since Specialization
Citations

This map shows the geographic impact of Emma A. Harden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma A. Harden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma A. Harden more than expected).

Fields of papers citing papers by Emma A. Harden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma A. Harden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma A. Harden. The network helps show where Emma A. Harden may publish in the future.

Co-authorship network of co-authors of Emma A. Harden

This figure shows the co-authorship network connecting the top 25 collaborators of Emma A. Harden. A scholar is included among the top collaborators of Emma A. Harden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma A. Harden. Emma A. Harden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shablykin, Oleh, Kathy A. Keith, Emma A. Harden, et al.. (2023). In vitro activity of novel 4-iminohydantoin sulfamide derivatives against human cytomegalovirus. Chemical Papers. 78(1). 133–140. 2 indexed citations
2.
Kovalishyn, Vasyl, Kathy A. Keith, Emma A. Harden, et al.. (2023). In Silico Design and Experimental Validation of Novel Oxazole Derivatives Against Varicella zoster virus. Molecular Biotechnology. 66(4). 707–717. 1 indexed citations
3.
Kovalishyn, Vasyl, Kathy A. Keith, Emma A. Harden, et al.. (2021). Design of new imidazole derivatives with anti-HCMV activity: QSAR modeling, synthesis and biological testing. Journal of Computer-Aided Molecular Design. 35(12). 1177–1187. 11 indexed citations
4.
Hartline, Caroll B., et al.. (2019). In vitro activity of novel derivatives of 1,3-oxazole-4-carboxylate and 1,3-oxazole-4-carbonitrile against human cytomegalovirus. Medicinal Chemistry Research. 28(8). 1205–1211. 9 indexed citations
5.
Hartline, Caroll B., et al.. (2018). A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesviruses. Antiviral Research. 159. 104–112. 25 indexed citations
6.
Prichard, Mark N., John D. Williams, Gloria Komazin-Meredith, et al.. (2013). Synthesis and Antiviral Activities of Methylenecyclopropane Analogs with 6-Alkoxy and 6-Alkylthio Substitutions That Exhibit Broad-Spectrum Antiviral Activity against Human Herpesviruses. Antimicrobial Agents and Chemotherapy. 57(8). 3518–3527. 38 indexed citations
7.
Williams, John D., Atiyya R. Khan, Emma A. Harden, et al.. (2012). Synthesis and antiviral activity of certain second generation methylenecyclopropane nucleosides. Bioorganic & Medicinal Chemistry. 20(12). 3710–3718. 8 indexed citations
8.
Prichard, Mark N., Earl R. Kern, Caroll B. Hartline, et al.. (2011). CMX001 Potentiates the Efficacy of Acyclovir in Herpes Simplex Virus Infections. Antiviral Research. 90(2). A25–A25.
9.
Keith, Kathy A., Emma A. Harden, Rachel Gill, et al.. (2010). Efficacy of N-methanocarbathymidine Against Herpes Simplex Virus is Cell Cycle Dependent. Antiviral Research. 86(1). A58–A58. 2 indexed citations
10.
Prichard, Mark N., Debra C. Quenelle, Caroll B. Hartline, et al.. (2009). Inhibition of Herpesvirus Replication by 5-Substituted 4′-Thiopyrimidine Nucleosides. Antimicrobial Agents and Chemotherapy. 53(12). 5251–5258. 36 indexed citations
11.
Harden, Emma A., Kathy A. Keith, Shannon L. Daily, et al.. (2009). Mutation of the Thymidine Kinases Encoded by Herpes Simplex Virus or Vaccinia Virus can Confer Resistance to 5-Iodo-4′-thio-2′-deoxyuridine. Antiviral Research. 82(2). A48–A48. 1 indexed citations
12.
Quenelle, Debra C., Mark N. Prichard, Emma A. Harden, et al.. (2009). Comparative Efficacy of Treatment with CMX001 Versus Acyclovir in BALB/c Mice Infected with Herpes Simplex Virus. Antiviral Research. 82(2). A51–A52. 1 indexed citations
13.
Harden, Emma A., Ruth Falshaw, Susan Carnachan, Earl R. Kern, & Mark N. Prichard. (2009). Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. Antiviral Research. 83(3). 282–289. 143 indexed citations
14.
Harden, Emma A., Caroll B. Hartline, Ruth Falshaw, et al.. (2008). Virucidal Activity of Extracts from Four Algae Species Against Herpes Simplex Virus. Antiviral Research. 78(2). A57–A57. 2 indexed citations
15.
Prichard, Mark N., Angela D. Williams, Kathy A. Keith, Emma A. Harden, & Earl R. Kern. (2006). Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs. Antiviral Research. 71(1). 1–6. 17 indexed citations
16.
Hartline, Caroll B., Emma A. Harden, Shannon L. Daily, et al.. (2005). Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro. Antimicrobial Agents and Chemotherapy. 49(9). 3724–3733. 106 indexed citations
17.
Hartline, Caroll B., et al.. (2004). Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity. Antiviral Research. 65(2). 97–105. 56 indexed citations
18.
Kushner, Nicole L., Stephanie L. Williams, Caroll B. Hartline, et al.. (2003). Efficacy of Methylenecyclopropane Analogs of Nucleosides Against Herpesvirus Replication In Vitro. Nucleosides Nucleotides & Nucleic Acids. 22(12). 2105–2119. 19 indexed citations
19.
Kern, Earl R., Caroll B. Hartline, Emma A. Harden, et al.. (2002). Enhanced Inhibition of Orthopoxvirus Replication In Vitro by Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir. Antimicrobial Agents and Chemotherapy. 46(4). 991–995. 163 indexed citations
20.
Rybak, Rachel J., Caroll B. Hartline, Yao‐Ling Qiu, et al.. (2000). In Vitro Activities of Methylenecyclopropane Analogues of Nucleosides and Their Phosphoralaninate Prodrugs against Cytomegalovirus and Other Herpesvirus Infections. Antimicrobial Agents and Chemotherapy. 44(6). 1506–1511. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabrina Auerochs Breakdown of academic impact, for papers by D. Reymen Breakdown of academic impact, for papers by Teresa H. Bacon Breakdown of academic impact, for papers by Matloob Husain Breakdown of academic impact, for papers by L. J. N. Ross Breakdown of academic impact, for papers by Annalisa Macagno Breakdown of academic impact, for papers by C G Bridges Breakdown of academic impact, for papers by Chen‐Wen Yao Breakdown of academic impact, for papers by Olga Hrušková‐Heidingsfeldová Breakdown of academic impact, for papers by Elcira C. Villarreal
Rankless by CCL
2026